NO20010860L - Nye forbindelser - Google Patents

Nye forbindelser

Info

Publication number
NO20010860L
NO20010860L NO20010860A NO20010860A NO20010860L NO 20010860 L NO20010860 L NO 20010860L NO 20010860 A NO20010860 A NO 20010860A NO 20010860 A NO20010860 A NO 20010860A NO 20010860 L NO20010860 L NO 20010860L
Authority
NO
Norway
Prior art keywords
new connections
prevention
formula
treatment
acceptable salts
Prior art date
Application number
NO20010860A
Other languages
English (en)
Norwegian (no)
Other versions
NO20010860D0 (no
Inventor
Amin Kosrat
Mikael Dahlstroem
Peter Nordberg
Ingemar Starke
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20010860D0 publication Critical patent/NO20010860D0/no
Publication of NO20010860L publication Critical patent/NO20010860L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO20010860A 1998-08-21 2001-02-20 Nye forbindelser NO20010860L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9802794A SE9802794D0 (sv) 1998-08-21 1998-08-21 New compounds
PCT/SE1999/001402 WO2000011000A2 (en) 1998-08-21 1999-08-18 New compounds

Publications (2)

Publication Number Publication Date
NO20010860D0 NO20010860D0 (no) 2001-02-20
NO20010860L true NO20010860L (no) 2001-04-23

Family

ID=20412307

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010860A NO20010860L (no) 1998-08-21 2001-02-20 Nye forbindelser

Country Status (20)

Country Link
US (3) US6579884B1 (de)
EP (2) EP1105391B1 (de)
JP (1) JP2002523415A (de)
KR (1) KR20010072798A (de)
CN (1) CN1329613A (de)
AR (1) AR020226A1 (de)
AT (1) ATE280768T1 (de)
AU (1) AU5767999A (de)
BR (1) BR9913103A (de)
CA (1) CA2339286A1 (de)
DE (1) DE69921483T2 (de)
DK (1) DK1105391T3 (de)
ES (1) ES2229763T3 (de)
IL (1) IL141166A0 (de)
NO (1) NO20010860L (de)
PT (1) PT1105391E (de)
SE (1) SE9802794D0 (de)
SI (1) SI1105391T1 (de)
WO (1) WO2000011000A2 (de)
ZA (1) ZA200100913B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
SE0003186D0 (sv) * 2000-09-07 2000-09-07 Astrazeneca Ab New process
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
SE0102808D0 (sv) * 2001-08-22 2001-08-22 Astrazeneca Ab New compounds
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
AR041292A1 (es) * 2002-09-19 2005-05-11 Schering Corp Pirazolopiridinas como inhibidores de quinasa dependientes de ciclina
MY133311A (en) * 2002-09-19 2007-11-30 Schering Corp Novel imidazopyridines as cyclin dependent kinase inhibitors
ES2335498T3 (es) 2003-03-10 2010-03-29 Nycomed Gmbh Nuevo proceso para la preparacion de reflumilast.
SE0301904D0 (sv) 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound II with therapeutic effect
US8536492B2 (en) * 2003-10-27 2013-09-17 Applied Materials, Inc. Processing multilayer semiconductors with multiple heat sources
KR20060099524A (ko) 2003-11-03 2006-09-19 아스트라제네카 아베 무증상 위식도 역류의 치료를 위한 이미다조[1,2-a]피리딘유도체
EP1711498A2 (de) * 2004-01-26 2006-10-18 Altana Pharma AG 1,2,4-triazolo[1,5-a]pyridine als inhibitoren der sekretion von magensäure
KR101764575B1 (ko) * 2004-07-28 2017-08-03 다케다 야쿠힌 고교 가부시키가이샤 피롤로〔2,3-c〕피리딘 화합물, 그 제조 방법 및 용도
US8663694B2 (en) * 2005-03-16 2014-03-04 Takeda Gmbh Taste masked dosage form containing roflumilast
JP2010511019A (ja) * 2006-12-01 2010-04-08 ガラパゴス・ナムローゼ・フェンノートシャップ 変性疾患及び炎症性疾患の治療に有用なイミダゾロピリジン化合物
EP2215074B1 (de) * 2007-09-27 2014-02-19 The United States of America, as Represented by the Secretary, Department of Health and Human Services Isoindolinverbindungen zur behandlung von spinaler muskelatrophie und für andere anwendungen
KR101605063B1 (ko) 2009-07-09 2016-03-21 라퀄리아 파마 인코포레이티드 소화관 운동이상이 관여하는 질환의 치료용 산 펌프 길항제
CN111606846A (zh) * 2020-05-12 2020-09-01 广州理文科技有限公司 一种n`-三氟甲磺酰基n杂芳香胺类化合物及其制备方法
CN121866256A (zh) * 2023-09-15 2026-04-14 株式会社汇恩斯 用于预防、减轻或治疗胃肠炎性疾病或胃酸相关疾病的新的基于咪唑并吡啶的化合物和包含其作为活性成分的组合物
KR102902555B1 (ko) * 2023-09-15 2025-12-24 (주)휴온스 신규한 이미다조피리딘계 화합물 및 이를 유효성분으로 포함하는 위장관 염증질환 또는 위산-관련 질환의 예방, 개선 또는 치료용 조성물

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
DE3269604D1 (en) * 1981-06-26 1986-04-10 Schering Corp Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4725601A (en) * 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
US5574042A (en) * 1992-11-02 1996-11-12 Fujisawa Pharmaceutical Co., Ltd Imidazo [1,2-a] pyridines and their pharmaceutical use
IL108520A (en) * 1993-02-15 1997-09-30 Byk Gulden Lomberg Chem Fab 2, 3, 8-TRISUBSTITUTED IMIDAZO £1, 2-a| PYRIDINE DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
EP0695303B1 (de) 1993-04-22 2001-11-28 Byk Gulden Lomberg Chemische Fabrik GmbH Pyridiniumsalze und ihre verwendung zur bekämpfung von helicobacter-bakterien
UA48122C2 (uk) 1993-10-11 2002-08-15 Бік Гульден Ломберг Хеміше Фабрік Гмбх АЛКОКСІАЛКІЛКАРБАМАТИ ІМІДАЗО[1,2-а]ПІРИДИНІВ, СПОСІБ ЇХ ОДЕРЖАННЯ ТА ЛІКАРСЬКИЙ ЗАСІБ НА ЇХ ОСНОВІ
JPH10505331A (ja) * 1994-07-28 1998-05-26 ビイク グルデン ロンベルク ヒェーミッシェ ファブリーク ゲゼルシャフト ミット ベシュレンクテル ハフツング ベンジルイミダゾピリジン
EP0773945A1 (de) 1994-07-28 1997-05-21 Byk Gulden Lomberg Chemische Fabrik GmbH Acylimidazopyridine
WO1996003405A1 (de) * 1994-07-28 1996-02-08 Byk Gulden Lomberg Chemische Fabrik Gmbh Imidazopyridin-azolidinone
AU3221795A (en) * 1994-07-28 1996-02-22 Byk Gulden Lomberg Chemische Fabrik Gmbh Halogenated imidazopyridines
DE19602853A1 (de) * 1996-01-26 1997-07-31 Byk Gulden Lomberg Chem Fab Neue Halogenimidazopyridine
US6096758A (en) 1996-01-26 2000-08-01 Byk Gulden Lomberg Chemische Fabrik Gmbh 3-methylimidazopyridines
SE9700661D0 (sv) * 1997-02-25 1997-02-25 Astra Ab New compounds
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds
SE9802793D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds

Also Published As

Publication number Publication date
DK1105391T3 (da) 2005-01-24
IL141166A0 (en) 2002-02-10
US6790960B2 (en) 2004-09-14
CN1329613A (zh) 2002-01-02
PT1105391E (pt) 2005-01-31
US20050154007A1 (en) 2005-07-14
NO20010860D0 (no) 2001-02-20
EP1411056A3 (de) 2004-04-28
US20030220364A1 (en) 2003-11-27
EP1105391A2 (de) 2001-06-13
BR9913103A (pt) 2001-05-08
EP1411056A2 (de) 2004-04-21
AR020226A1 (es) 2002-05-02
ATE280768T1 (de) 2004-11-15
WO2000011000A3 (en) 2000-06-15
JP2002523415A (ja) 2002-07-30
DE69921483T2 (de) 2006-02-02
DE69921483D1 (de) 2004-12-02
SI1105391T1 (en) 2005-02-28
ZA200100913B (en) 2002-05-02
WO2000011000A2 (en) 2000-03-02
KR20010072798A (ko) 2001-07-31
US6579884B1 (en) 2003-06-17
AU5767999A (en) 2000-03-14
ES2229763T3 (es) 2005-04-16
CA2339286A1 (en) 2000-03-02
EP1105391B1 (de) 2004-10-27
SE9802794D0 (sv) 1998-08-21

Similar Documents

Publication Publication Date Title
NO20010860L (no) Nye forbindelser
NO20010861L (no) Nye forbindelser
SE9801526D0 (sv) New compounds
SE9704404D0 (sv) New compounds
SE9700661D0 (sv) New compounds
CA2256687A1 (en) Benzimidazole derivatives for treating gastrointestinal inflammatory diseases
SE9401197D0 (sv) Active compounds
SE0102808D0 (sv) New compounds
ATE311389T1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
ATE417856T1 (de) Motilidverbindungen
WO2002074735A3 (de) Biurethanderivate
NO954928L (no) Nye aktive forbindelser
SE0301905D0 (sv) Novel imidazopyridine compound I with therapeutic effect
SE0102640D0 (sv) Novel compounds
NZ329716A (en) Sulfonamide substituted derivatives and medicaments thereof
AR044855A1 (es) Compuesto de imidazopiridina
MX9704136A (es) Compuestos para la inhibicion de la secrecion de acido gastrico.
NO20072340L (no) Difluorsubstituerte Imidazopyridiner
ATE382616T1 (de) Neue verbindungen
AR044854A1 (es) Compuesto de imidazopiridina
NO921691L (no) Farmasoeytisk preparat

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application